
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 June 25
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Serve as a field-based scientific expert supporting external engagement with healthcare professionals, investigators, treatment centers, and KOLs focused on autoimmune diseases and cell therapy. • Identify, establish, and maintain high‑quality scientific relationships with KOLs, investigators, academic medical centers, community physicians, pharmacists, nurses, and treatment centers within the assigned territory. • Serve as a trusted scientific partner by providing fair‑balanced, accurate, and compliant scientific exchange related to disease state, treatment landscape, Kyverna’s CAR‑T programs, and emerging clinical data. • Act as a primary scientific liaison to investigators interested in clinical research collaborations and investigator‑initiated research discussions. • Develop and execute geography‑specific Medical Affairs and KOL engagement plans aligned with therapeutic area objectives, investigator needs, and Kyverna’s medical strategy. • Demonstrate ownership of the assigned territory through stakeholder mapping, prioritization, and proactive planning. • Collaborate with Clinical Development and Clinical Operations to support Kyverna‑sponsored clinical trials. • Capture and communicate timely, high‑quality medical insights related to the autoimmune and cell therapy landscape to internal stakeholders to support strategy and evidence planning. • Provide scientific support at national, regional, and local congresses, advisory boards, investigator meetings, and medical education forums.
• Advanced scientific or clinical degree required (MD, PharmD, PhD, DNP, NP, PA, or equivalent). • Medical Science Liaison (MSL) requires Doctorate degree OR Master’s degree & 3 years of Medical Affairs experience • Senior Medical Science Liaison (Senior MSL) requires Doctorate degree & 2 years of Medical Affairs experience OR Master’s degree & 6 years of Medical Affairs experience • Prior experience in cell therapy, CAR-T, immunology, rheumatology, nephrology, neurology, hematology/oncology, or rare diseases strongly preferred. • Strong understanding of clinical trial design, clinical development, and medical affairs functions. • Experience engaging with academic medical centers, specialty treatment centers, and/or infusion centers preferred. • Ability to interpret and communicate complex scientific and clinical information to diverse audiences. • Excellent presentation, communication, and interpersonal skills. • Demonstrated ability to build strong external relationships and collaborate effectively across cross-functional teams. • Comfortable operating within a fast-paced, high-growth biotechnology environment. • Willingness and ability to travel extensively within assigned geography. • Experience supporting pre-commercial or launch-stage biotechnology organizations. • Knowledge of autoimmune disease treatment landscapes and emerging cell therapy approaches. • Experience supporting investigator-sponsored research and clinical trial recruitment initiatives. • Familiarity with cell therapy operational concepts including chain of identity, chain of custody, and treatment center workflows.
• bonus • benefits • participation in Company’s stock plan
Apply Now🕒 June 25
Medical Science Liaison responsible for engaging with healthcare professionals in hematology and oncology. Supporting medical education and research initiatives at PharmaEssentia.
🇺🇸 United States – Remote
💵 $165.2k - $238.7k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor
🕒 June 25
Medical Science Liaison at PharmaEssentia exchanging medical information with healthcare professionals and supporting key opinion leaders. Focusing on hematology and oncology treatments in North America.
🇺🇸 United States – Remote
💵 $165.2k - $238.7k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor
🕒 June 25
Medical Science Liaison managing key relationships and communications in the hematology and oncology fields. Fostering connections with health care professionals for PharmaEssentia's innovative biologics.
🇺🇸 United States – Remote
💵 $165.2k - $238.7k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor
🕒 June 25
Medical Science Liaison managing relationships with physicians and medical centers in hematology and oncology. Providing scientific support and communication to the medical community and ensuring alignment with commercial objectives.
🇺🇸 United States – Remote
💵 $165.2k - $238.7k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🦅 H1B Visa Sponsor
🕒 June 25
Experienced Medical Science Liaison engaging with healthcare professionals in the cardiometabolic therapeutic area for Arrowhead Pharmaceuticals. Focusing on education and scientific exchange regarding innovative RNAi therapies.